Pulmonary emphysema in alpha-1 antitrypsin deficiency

Clinical trials for Pulmonary emphysema in alpha-1 antitrypsin deficiency explained in plain language.

Never miss a new study

Get alerted when new Pulmonary emphysema in alpha-1 antitrypsin deficiency trials appear

Sign up with your email to follow new studies for Pulmonary emphysema in alpha-1 antitrypsin deficiency, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New study checks safety of weekly infusion for rare lung disease

Disease control By invitation only

This study looks at the long-term safety of a weekly intravenous treatment for people with emphysema caused by alpha-1 antitrypsin deficiency. About 290 adults who completed a prior study will receive the drug for 2 more years. The main goal is to monitor side effects, not to cur…

Matched conditions: PULMONARY EMPHYSEMA IN ALPHA-1 ANTITRYPSIN DEFICIENCY

Phase 3 • Sponsor: Grifols Therapeutics LLC • Aim: Disease control

Last updated Jun 27, 2026 14:02 UTC

Pulmonary emphysema in alpha-1 antitrypsin deficiency

Get alerted when new Pulmonary emphysema in alpha-1 antitrypsin deficiency trials appear

New study checks safety of weekly infusion for rare lung disease